Thermosensitive in situ liposomal gels loaded with antimicrobial agent for oral care in critically ill patients

Ther Deliv. 2020 Apr;11(4):231-243. doi: 10.4155/tde-2019-0092. Epub 2020 Apr 29.

Abstract

Aim: A novel thermosensitive in situ gel loaded with meropenem (MP) liposomes was designed to improve retention in the oral cavity as a prophylactic measure to prevent ventilator-acquired pneumonia in critically ill patients. Methodology & results: Meropenem liposomes were incorporated into poloxamer 407 gels and gamma irradiated. Mean size of liposome was 247 nm, polydispersity index < 0.3 and zeta potential >-25 mV; properties remained unaltered even post sterilization. Permeation study revealed that 75.26% and 34% of MPs were released from MP in situ gel and MP in situ liposomal gel, respectively. The relation between viscosity (cp) and shear rate (1/s) indicate that in situ gels exhibited non-Newtonian behavior at 37°C. The study using Pseudomonas aeruginosa confirmed the antimicrobial activity of meropenem. Conclusion: Prolonged in situ residence, because of rapid gelation process enables an easy administration of meropenem as liposomal suspension in critically ill patients.

Keywords: VAP; gamma irradiation; in situ gel; liposomes; meropenem; nosocomial infection; ventilator-acquired pneumonia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents*
  • Critical Illness
  • Gels / chemistry*
  • Humans
  • Liposomes*
  • Poloxamer / chemistry*
  • Temperature*

Substances

  • Anti-Bacterial Agents
  • Gels
  • Liposomes
  • Poloxamer